EGFR and neoplasm: Here, it dissects the molecular mechanisms underlying NK cell dysfunction in cutaneous malignancies and identifies a paradoxical cytokine shift in tumor‐associated NK cells–reduced production of IFN‐γ and TNF‐α alongside elevated amphiregulin (AREG), an EGFR ligand linked to tumor progression.